Dongcheng Biochemicals Stages $110 Million IPO in Shenzhen
Published: May 29, 2012
May 25, 2012 -- Yantai Dongcheng Biochemicals has completed a $110 million IPO on Shenzhen’s Small and Medium-Sized Enterprises Board. The main products from Dongcheng Biochemicals, which makes APIs and finished products, are heparin sodium and chondroitin sulphate, a dietary supplement that treats osteoarthritis. More details....
Stock Symbol: (SHE: 002675)